• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

  • Print
  • Share
  • E-mail
-

Patent and Exclusivity Search Results from query on Appl No 022287 Product 001 in the OB_Rx list.


Patent Data

Appl No Prod No Patent No Patent
Expiration
Drug Substance
Claim
Drug Product
Claim
Patent Use
Code
Delist
Requested
N022287 001 6462058 Jun 15, 2020 Y Y U - 949
N022287 001 6462058 Jun 15, 2020 Y Y U - 950
N022287 001 6462058 Jun 15, 2020 Y Y U - 951
N022287 001 6462058*PED Dec 15, 2020
N022287 001 6664276 Jan 30, 2023 Y Y U - 951
N022287 001 6664276 Jan 30, 2023 Y Y U - 950
N022287 001 6664276 Jan 30, 2023 Y Y U - 1507
N022287 001 6664276 Jan 30, 2023 Y Y U - 949
N022287 001 6664276*PED Jul 30, 2023
N022287 001 6939971 Jun 15, 2020 U - 949
N022287 001 6939971 Jun 15, 2020 U - 950
N022287 001 6939971 Jun 15, 2020 U - 951
N022287 001 6939971*PED Dec 15, 2020
N022287 001 7285668 Jun 15, 2020 Y
N022287 001 7285668*PED Dec 15, 2020
N022287 001 7790755 Aug 2, 2026 Y
N022287 001 7790755*PED Feb 2, 2027
N022287 001 8105626 Sep 27, 2026 Y
N022287 001 8105626*PED Mar 27, 2027
N022287 001 8173158 Mar 17, 2030 U - 949
N022287 001 8173158 Mar 17, 2030 U - 950
N022287 001 8173158 Mar 17, 2030 U - 951
N022287 001 8173158*PED Sep 17, 2030
N022287 001 8461187 Jan 17, 2026 Y
N022287 001 8461187*PED Jul 17, 2026
N022287 001 8722084 Oct 15, 2023 Y
N022287 001 8784885 Oct 15, 2023 Y U - 1553
N022287 001 8784885 Oct 15, 2023 Y U - 1552
N022287 001 8784885 Oct 15, 2023 Y U - 1554

Exclusivity Data

There is no unexpired exclusivity for this product.


Additional information:

  1. Patents are published upon receipt by the Orange Book Staff and may not reflect the official receipt date as described in 21 CFR 314.53(d)(5).
  2. Patents listed prior to August 18, 2003 are flagged with method of use claims only as applicable and submitted by the sponsor. These patents may not be flagged with respect to other claims which may apply.


View a list of all patent use codes
View a list of all exclusivity codes

Return to Electronic Orange Book Home Page


FDA/Center for Drug Evaluation and Research
Office of Generic Drugs
Division of Labeling and Program Support
Update Frequency:

Orange Book Data - Monthly
Generic Drug Product Information & Patent Information - Daily
Orange Book Data Updated Through August 2014
Patent and Generic Drug Product Data Last Updated September 17, 2014

-
-